Tirzepatide in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification?

Background: Obesity is a major driver of obstructive sleep apnea (OSA), traditionally managed as a mechanical disorder of upper airway collapse. However, growing evidence supports a broader pathophysiological model involving metabolic dysfunction, systemic inflammation, and ventilatory instability....

Celý popis

Podrobná bibliografie

Hlavní autoři:	Florin-Dumitru Mihălțan, Corina Ioana Borcea, Ancuța Alina Constantin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-05-01
Edice:	Life
Témata:	obesity obstructive sleep apnea tirzepatide GLP-1/GIP receptor agonists cardiometabolic risk public health burden
On-line přístup:	https://www.mdpi.com/2075-1729/16/5/802
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!